James Gray
Analyst · Credit Suisse. Please go ahead
Thanks Jim. Good morning, everyone. Let me start by covering the highlights of the income statement. Net sales were up for the quarter. Higher volumes and foreign exchange more than offset lower price/mix. Gross profit was higher by $21 million as a result of margin expansion in South America and EMEA, the inclusion of the TIC Gums business, and specialty ingredient volume growth. Reported and adjusted operating incomes were $203 million and $210 million, respectively. Reported operating income was lower than adjusted operating income by $7 million. This difference is driven by restructuring costs related to a $13 million write-down of certain stevia leaf extraction assets, severance of $2 million, and acquisition and integration costs associated with TIC Gums were $1 million. Offsetting these charges was $9 million from insurance recovery primarily related to capital reconstruction. Our reported and adjusted earnings per share were $1.35 and $1.73 respectively. Besides the reconciling items I just mentioned, reported earnings per share were lower than adjusted earnings, given the enactment of the Tax Cuts and Jobs Act in December 2017 which resulted in a one-time estimated charge of $23 million in the fourth quarter. The estimated charge includes the transition tax on accumulated earnings overseas and foreign taxes on a portion of our unremitted earnings, partially offset by the remeasurement of net deferred tax liabilities. Moving on to the net sales bridge, our sales were up versus last year. FX contributed $12 million, while volume contributed $42 million. This was partially offset by $16 million of unfavorable price/mix, which was largely driven by the pass-through of lower raw material costs in Brazil. As we look more closely by region, you can see unfavorable foreign exchange affected South America, but was offset by favorable foreign exchange in Asia Pacific and EMEA. Volumes were up in all four regions. In North America, volume was up, driven by our TIC Gums acquisition. In Asia Pacific, volume was up, given our specialty capacity expansions. However, price/mix was down due to our decision to diversify our core Korea customer mix. In South America, price/mix was down, driven by the pass-through of lower raw material costs. EMEA was strong in volume and price/mix driven by specialty and core ingredient growth. For the quarter, reported operating income increase $14 million, while adjusted operating income increased $16 million. North America operating income increased due to acquisition related volumes and effective pass-through changes in raw material costs, partially offset by higher operating costs in Mexico. South America operating income was driven. It was up driven by volume growth in our more competitive cost structure from network optimization and restructuring. Asia Pacific was flat given that volume growth was offset by higher tapioca costs, which spiked during the quarter given supply shortfall. Given the magnitude of the tapioca crop shortfall and relative strength of the Thai baht during the quarter, we expect a price recovery lag of six to nine months. EMEA was up $4 million driven by volume growth and favorable price mix, corporate costs were lower by $1 million for the quarter, given smart cost discipline and timing of expenses. We will wrap up the discussion of the quarter with the earnings per share. On the left side of the page, you can see the reconciliation from reported to adjusted. On the right side, operationally, we saw an improvement of $0.15 per share primarily the result of volume due to acquisition and specialty related ingredients with a lesser benefit from foreign exchange. This was partially offset by a margin of minus $0.03 per share primarily driven by higher operating costs in Mexico as well as the increase of tapioca costs in Asia Pacific. Moving to our non-operational items we recognized a decrease of $0.09 per share for the quarter. Adjusted taxes were minus $0.13 per share, largely driven by decrease foreign tax credits in 2017 as compared to the year-ago period. The higher tax rate was partially offset by a $0.02 per share benefit from fewer shares outstanding and $0.02 per share benefit from lower financing costs. Turning to our full-year figures, net sales were up 2%. Higher volumes in foreign exchange more than offset lower price mix. Gross profit was higher by $71 million as a result of margin expansion in North America and higher volumes from the inclusion of the TIC Gums business and organic growth and specialty ingredients globally. Reported and adjusted operating incomes were $842 million and $884 million respectively. Reported operating income was lower than adjusted operating income by $42 million. This difference is largely related to pre-tax restructuring charges of $17 million in Argentina for employee severance as we took action to improve efficiency and lower our operating costs, a $13 million write-down for certain stevia leaf extraction assets, $6 million for our finance transformation initiative and $2 millions of other severance. Additionally, we had pre-tax expense of $13 million for integration and acquisition costs, including the fair value mark of acquired TIC Gums inventory. This was partially offset by the $9 million of insurance recovery, I talked about earlier. Our reported and adjusted earnings per share were $7.06 and $7.70 respectively. Moving on to the net sales bridge, our full-year sales were up versus last year. FX contributed $49 million. Furthermore, volume was the biggest driver and contributed one $165 million. This was partially offset by $86 million of price mix. Our price mix was largely driven by a pass-through of our raw material costs. As we look more closely by region, you can see foreign exchange was flat to favorable in all four regions. Volumes were up in North America, Asia Pacific and EMEA. In North America volume was up driven by a TIC Gums acquisition and Asia Pacific volume was up given our specialty capacity expansions. Price mix was down 2% largely driven by the pass-through of lower raw material costs in three of our four regions and the diversification of our core customer mix in Korea. For the year, reported operating income increase $34 million, while adjusted operating income increased $54 million. North America posted a strong result in a margin expansion driven by operational efficiencies and growth in acquisition and specialty related ingredients. South America operating income decreased by $9 million, the decrease was largely a result of Argentina's difficult macroeconomic conditions and the strike in Argentina and resulting temporary higher costs during the first half of this year. Asia Pacific and EMEA were up $1 million and $7 million respectively. Corporate costs were lower, given expense timing and smart cost discipline. Moving to earnings per share, operations drove an improvement of $0.52 per share, primarily the result of volume of $0.48 per share with a lesser benefit from foreign exchange of $0.12 and $0.03 per share of other income. This was partially offset by a margin impact of minus $0.11 per share. The lower margins were largely caused by South America with Argentina's difficult macroeconomic conditions and temporary higher costs during the first half of the year. Moving to our non-operational changes, we recognized a benefit of $0.05 per share. Our adjusted tax rate was lower, contributing $0.08 per share benefit driven by appreciation of the Mexican peso during the year and the result in valuation of U.S. dollar denominated balances in Mexico and a lower valuation allowance on the net deferred tax assets of a foreign subsidiary. Our shares outstanding had a per share benefit of $0.06. These benefits were offset by higher financing costs of minus $0.07 per share due a higher debt balance and higher interest rates. Moving to cash flow, our full-year cash flow provided by operations was $769 million. During the year, we deployed cash in the form of capital expenditures, dividends, share repurchases and acquisitions. Our full-year capital expenditures of $306 million were up $23 million from last year, primarily driven by growth and cost savings initiatives. I'd like to note that our full-year working capital was impacted by the timing associated with the U.S. Canada tax settlement. If you recall during the third quarter, we paid the U.S. $63 million, but do not anticipate receiving the offsetting payment of $45 million from the Canadian rebate until 2018. Turning to our guidance, we anticipate 2018 adjusted earnings per share in the range of $8.10 to $8.50. This includes the estimate benefit of tax reform of approximately one percentage point of ETR. Additionally, this guidance excludes acquisition-related integration and restructuring costs, as well as any potential impairment costs. We expect net sales and volumes to be up from 2017 and we expect continued growth in specialty sales. We anticipate that the impact of foreign exchange will be a neutral as we've explained in the past, given our business models, for most regions, foreign exchange is effectively a pass-through. We expect operating expenses including corporate expenses to be up year-over-year due to continued investments in innovation through R&D, customer experience and administrative processes to strengthen our capabilities and drive future efficiencies. We expect financing costs for the year to be in the range of $72 million to $77 million due to higher interest rates on our floating rate debt and our refinanced maturities. Our adjusted effective annual tax rate is expected to be 27.5% to 29% this reflects of benefit from U.S. tax reform of approximately one percentage point on our globally weighted effective tax rate. We expect total diluted weighted average shares outstanding to be in the range of 73.5 million to 74 million for the year. I want to highlight the new accounting standard update related to presentation of pension expense and its implication to our operating income. In 2017 our net pension expense was about $4 million for the company this includes the service cost of about $10 million offset by $6 million of income net and other components which relates to the expected return on the pension assets. Beginning in 2018 our operating income will reflect only the service costs. While the other components in this case $6 million in income will be classified as other non-operating income. The presentation change will impact regional operating income however there is really no impact on net income or earnings per share. Beginning in the first quarter of 2018 we will reflect the impact of this accounting standards update in our results and will restate prior periods for comparability. Turning to the regional outlook. In North America, we expect net sales to be up. For the full-year, we expect operating income to be above the 2016 level in the low single to mid single-digits with improved product mix and margins is during in the latter half of the year. Additionally, our guidance for Mexico assumes higher operating costs due to general inflation and increased sweetener price competition from U.S. imports. South American net sales are expected to be flat to up versus prior year, volume recovery and favorable price/mix are expected to offset forecasted foreign exchange headwinds, and operating income is expected to be up. In addition, we anticipate positive economic growth in Brazil, and we remain slightly optimistic regarding economic reforms in Argentina, and the impacts on our Southern Cone business. We continue to focus on business performance improvement and expect operating income improvement in the region. Asia Pacific net sales are expected to be up, but operating income growth is not expected until the latter half of the year given tapioca cost headwinds. EMEA should continue to deliver net sales in operating income growth. We expect improved core and specialty volume growth. We continue to monitor the political environment in Pakistan and potential risks to our business. We expect cash from operations in 2018 to be in the range of $830 million to $880 million. We expect to invest between $330 million and $360 million in capital expenditures around the world in 2018 to support growth as well as cost and process improvements. Importantly, we have a proven track record of both reinvesting and returning capital to shareholders through dividends and share repurchases, and we expect to continue this in the future as we concurrently explore M&A opportunities. That brings my comments to a close. Back to Mr. Zallie.